A randomized, open-label, cross-over, single administration study to compare bioavailability of curcumin in health adults
* Randomization, Open-label, 3-period, 6-sequence, Crossover, Single * Drug-free inverval : more than 7 days * Sampling time : 0,0.5,1,1.5,2,3,4,6,8,12h
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
24
curcumin 90mg/day cross-over
Korea Kuro Hospital
Seoul, South Korea
Cmax
Maximum concentration at steady state
Time frame: 12hours
AUC
Area under the concentration-time curve at steady state
Time frame: 12hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.